InsidersTradesSigma
Follow the Australian Clinical Labs Limited share price and the full insider trade history of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Operating in the Health Care sector, Australian Clinical Labs Limited has published 15 public disclosures. Market capitalisation: €557.7m. The latest transaction was filed on 24 August 2026 (Cease Substantial Holding). Among the most active insiders: There was a change in the interests of the. The full history is accessible without an account.
15
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Australian Clinical Labs Limited Buy (bullish), based on 8 analysts. Average price target: A$2.88.
Fundamental score
Ranked 1,645 of 28,985 companies
78.1
score / 100
Value88
Quality69
FCF yld33%
Earn yld6.2%
EV/EBITDA4.3x
ROE15%
Gross mgn83%
Net mgn4.4%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 August 2026
Declarations15 total
ShareASXISIN AU0000148496ASX:2924-03124420-3A699463
ShareASXISIN AU0000148496ASX:2924-03123811-3A699350
ShareASXISIN AU0000148496ASX:2924-03112073-3A697333
ShareASXISIN AU0000148496ASX:2924-03111737-3A697278
●
ShareASXISIN AU0000148496ASX:2924-03092202-3A693702
ShareASXISIN AU0000148496ASX:2924-03092061-3A693677
ShareASXISIN AU0000148496ASX:2924-03086307-3A692634
ShareASXISIN AU0000148496ASX:2924-03082737-3A692020
15 of 15 declarations
About Australian Clinical Labs Limited
Australian Clinical Labs Limited is an Australian company specializing in clinical laboratory services. It provides diagnostic testing and medical analysis across the country.